img

Global Pneumococcal Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pneumococcal Vaccination Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
Pneumococcal Vaccination report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pneumococcal Vaccination market is projected to reach US$ 16100 million in 2029, increasing from US$ 7841.5 million in 2022, with the CAGR of 10.6% during the period of 2024 to 2029. Demand from Child and Adult are the major drivers for the industry.
The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pneumococcal Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai
Segment by Type
PPSV 23
PCV 13
PCV 10

Segment by Application


Child
Adult

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pneumococcal Vaccination market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pneumococcal Vaccination, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pneumococcal Vaccination industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pneumococcal Vaccination in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pneumococcal Vaccination introduction, etc. Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pneumococcal Vaccination market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Pneumococcal Vaccination Market Overview
1.1 Pneumococcal Vaccination Product Overview
1.2 Pneumococcal Vaccination Market Segment by Type
1.2.1 PPSV 23
1.2.2 PCV 13
1.2.3 PCV 10
1.3 Global Pneumococcal Vaccination Market Size by Type
1.3.1 Global Pneumococcal Vaccination Market Size Overview by Type (2018-2029)
1.3.2 Global Pneumococcal Vaccination Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pneumococcal Vaccination Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pneumococcal Vaccination Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pneumococcal Vaccination Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pneumococcal Vaccination Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pneumococcal Vaccination Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pneumococcal Vaccination Sales Breakdown by Type (2018-2024)
2 Global Pneumococcal Vaccination Market Competition by Company
2.1 Global Top Players by Pneumococcal Vaccination Sales (2018-2024)
2.2 Global Top Players by Pneumococcal Vaccination Revenue (2018-2024)
2.3 Global Top Players by Pneumococcal Vaccination Price (2018-2024)
2.4 Global Top Manufacturers Pneumococcal Vaccination Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pneumococcal Vaccination Market Competitive Situation and Trends
2.5.1 Pneumococcal Vaccination Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pneumococcal Vaccination Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Vaccination as of 2022)
2.7 Date of Key Manufacturers Enter into Pneumococcal Vaccination Market
2.8 Key Manufacturers Pneumococcal Vaccination Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pneumococcal Vaccination Status and Outlook by Region
3.1 Global Pneumococcal Vaccination Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pneumococcal Vaccination Historic Market Size by Region
3.2.1 Global Pneumococcal Vaccination Sales in Volume by Region (2018-2024)
3.2.2 Global Pneumococcal Vaccination Sales in Value by Region (2018-2024)
3.2.3 Global Pneumococcal Vaccination Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pneumococcal Vaccination Forecasted Market Size by Region
3.3.1 Global Pneumococcal Vaccination Sales in Volume by Region (2024-2029)
3.3.2 Global Pneumococcal Vaccination Sales in Value by Region (2024-2029)
3.3.3 Global Pneumococcal Vaccination Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pneumococcal Vaccination by Application
4.1 Pneumococcal Vaccination Market Segment by Application
4.1.1 Child
4.1.2 Adult
4.2 Global Pneumococcal Vaccination Market Size by Application
4.2.1 Global Pneumococcal Vaccination Market Size Overview by Application (2018-2029)
4.2.2 Global Pneumococcal Vaccination Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pneumococcal Vaccination Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pneumococcal Vaccination Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pneumococcal Vaccination Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pneumococcal Vaccination Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pneumococcal Vaccination Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pneumococcal Vaccination Sales Breakdown by Application (2018-2024)
5 North America Pneumococcal Vaccination by Country
5.1 North America Pneumococcal Vaccination Historic Market Size by Country
5.1.1 North America Pneumococcal Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pneumococcal Vaccination Sales in Volume by Country (2018-2024)
5.1.3 North America Pneumococcal Vaccination Sales in Value by Country (2018-2024)
5.2 North America Pneumococcal Vaccination Forecasted Market Size by Country
5.2.1 North America Pneumococcal Vaccination Sales in Volume by Country (2024-2029)
5.2.2 North America Pneumococcal Vaccination Sales in Value by Country (2024-2029)
6 Europe Pneumococcal Vaccination by Country
6.1 Europe Pneumococcal Vaccination Historic Market Size by Country
6.1.1 Europe Pneumococcal Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pneumococcal Vaccination Sales in Volume by Country (2018-2024)
6.1.3 Europe Pneumococcal Vaccination Sales in Value by Country (2018-2024)
6.2 Europe Pneumococcal Vaccination Forecasted Market Size by Country
6.2.1 Europe Pneumococcal Vaccination Sales in Volume by Country (2024-2029)
6.2.2 Europe Pneumococcal Vaccination Sales in Value by Country (2024-2029)
7 Asia-Pacific Pneumococcal Vaccination by Region
7.1 Asia-Pacific Pneumococcal Vaccination Historic Market Size by Region
7.1.1 Asia-Pacific Pneumococcal Vaccination Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pneumococcal Vaccination Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pneumococcal Vaccination Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pneumococcal Vaccination Forecasted Market Size by Region
7.2.1 Asia-Pacific Pneumococcal Vaccination Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pneumococcal Vaccination Sales in Value by Region (2024-2029)
8 Latin America Pneumococcal Vaccination by Country
8.1 Latin America Pneumococcal Vaccination Historic Market Size by Country
8.1.1 Latin America Pneumococcal Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pneumococcal Vaccination Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pneumococcal Vaccination Sales in Value by Country (2018-2024)
8.2 Latin America Pneumococcal Vaccination Forecasted Market Size by Country
8.2.1 Latin America Pneumococcal Vaccination Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pneumococcal Vaccination Sales in Value by Country (2024-2029)
9 Middle East and Africa Pneumococcal Vaccination by Country
9.1 Middle East and Africa Pneumococcal Vaccination Historic Market Size by Country
9.1.1 Middle East and Africa Pneumococcal Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pneumococcal Vaccination Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pneumococcal Vaccination Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pneumococcal Vaccination Forecasted Market Size by Country
9.2.1 Middle East and Africa Pneumococcal Vaccination Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pneumococcal Vaccination Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Pneumococcal Vaccination Products Offered
10.1.5 Pfizer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Pneumococcal Vaccination Products Offered
10.2.5 GSK Recent Development
10.3 MSD
10.3.1 MSD Company Information
10.3.2 MSD Introduction and Business Overview
10.3.3 MSD Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.3.4 MSD Pneumococcal Vaccination Products Offered
10.3.5 MSD Recent Development
10.4 CDIBP
10.4.1 CDIBP Company Information
10.4.2 CDIBP Introduction and Business Overview
10.4.3 CDIBP Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CDIBP Pneumococcal Vaccination Products Offered
10.4.5 CDIBP Recent Development
10.5 WALVAX
10.5.1 WALVAX Company Information
10.5.2 WALVAX Introduction and Business Overview
10.5.3 WALVAX Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.5.4 WALVAX Pneumococcal Vaccination Products Offered
10.5.5 WALVAX Recent Development
10.6 Sinovac
10.6.1 Sinovac Company Information
10.6.2 Sinovac Introduction and Business Overview
10.6.3 Sinovac Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sinovac Pneumococcal Vaccination Products Offered
10.6.5 Sinovac Recent Development
10.7 Bio Kangtai
10.7.1 Bio Kangtai Company Information
10.7.2 Bio Kangtai Introduction and Business Overview
10.7.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bio Kangtai Pneumococcal Vaccination Products Offered
10.7.5 Bio Kangtai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pneumococcal Vaccination Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pneumococcal Vaccination Industrial Chain Analysis
11.4 Pneumococcal Vaccination Market Dynamics
11.4.1 Pneumococcal Vaccination Industry Trends
11.4.2 Pneumococcal Vaccination Market Drivers
11.4.3 Pneumococcal Vaccination Market Challenges
11.4.4 Pneumococcal Vaccination Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pneumococcal Vaccination Distributors
12.3 Pneumococcal Vaccination Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PPSV 23
Table 2. Major Company of PCV 13
Table 3. Major Company of PCV 10
Table 4. Global Pneumococcal Vaccination Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pneumococcal Vaccination Sales by Type (2018-2024) & (K Units)
Table 6. Global Pneumococcal Vaccination Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Pneumococcal Vaccination Sales by Type (2018-2024) & (US& Million)
Table 8. Global Pneumococcal Vaccination Market Share in Value by Type (2018-2024)
Table 9. Global Pneumococcal Vaccination Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Pneumococcal Vaccination Sales by Type (2024-2029) & (K Units)
Table 11. Global Pneumococcal Vaccination Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Pneumococcal Vaccination Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Pneumococcal Vaccination Sales Market Share in Value by Type (2024-2029)
Table 14. Global Pneumococcal Vaccination Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Pneumococcal Vaccination Sales by Type (2018-2024) & (K Units)
Table 16. North America Pneumococcal Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Pneumococcal Vaccination Sales (K Units) by Type (2018-2024)
Table 18. Europe Pneumococcal Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Pneumococcal Vaccination Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Pneumococcal Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Pneumococcal Vaccination Sales (K Units) by Type (2018-2024)
Table 22. Latin America Pneumococcal Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Pneumococcal Vaccination Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Pneumococcal Vaccination Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Pneumococcal Vaccination Sales by Company (2018-2024) & (K Units)
Table 26. Global Pneumococcal Vaccination Sales Share by Company (2018-2024)
Table 27. Global Pneumococcal Vaccination Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Pneumococcal Vaccination Revenue Share by Company (2018-2024)
Table 29. Global Market Pneumococcal Vaccination Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Pneumococcal Vaccination Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Pneumococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Vaccination as of 2022)
Table 33. Date of Key Manufacturers Enter into Pneumococcal Vaccination Market
Table 34. Key Manufacturers Pneumococcal Vaccination Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Pneumococcal Vaccination Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Pneumococcal Vaccination Sales by Region (2018-2024) & (K Units)
Table 38. Global Pneumococcal Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Pneumococcal Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Pneumococcal Vaccination Sales Market Share in Value by Region (2018-2024)
Table 41. Global Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Pneumococcal Vaccination Sales by Region (2024-2029) & (K Units)
Table 43. Global Pneumococcal Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Pneumococcal Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Pneumococcal Vaccination Sales Market Share in Value by Region (2024-2029)
Table 46. Global Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Pneumococcal Vaccination Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Pneumococcal Vaccination Sales by Application (2018-2024) & (K Units)
Table 49. Global Pneumococcal Vaccination Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Pneumococcal Vaccination Sales Market Share in Value by Application (2018-2024)
Table 52. Global Pneumococcal Vaccination Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Pneumococcal Vaccination Sales by Application (2024-2029) & (K Units)
Table 54. Global Pneumococcal Vaccination Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Pneumococcal Vaccination Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Pneumococcal Vaccination Sales Market Share in Value by Application (2024-2029)
Table 57. Global Pneumococcal Vaccination Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Pneumococcal Vaccination Sales by Application (2018-2024) (K Units)
Table 59. North America Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Pneumococcal Vaccination Sales by Application (2018-2024) (K Units)
Table 61. Europe Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Pneumococcal Vaccination Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Pneumococcal Vaccination Sales by Application (2018-2024) (K Units)
Table 65. Latin America Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Pneumococcal Vaccination Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Pneumococcal Vaccination Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Pneumococcal Vaccination Sales by Country (2018-2024) & (K Units)
Table 69. North America Pneumococcal Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Pneumococcal Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Pneumococcal Vaccination Sales Market Share in Value by Country (2018-2024)
Table 72. North America Pneumococcal Vaccination Sales by Country (2024-2029) & (K Units)
Table 73. North America Pneumococcal Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Pneumococcal Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Pneumococcal Vaccination Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Pneumococcal Vaccination Sales by Country (2018-2024) & (K Units)
Table 77. Europe Pneumococcal Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Pneumococcal Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Pneumococcal Vaccination Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Pneumococcal Vaccination Sales by Country (2024-2029) & (K Units)
Table 81. Europe Pneumococcal Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Pneumococcal Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Pneumococcal Vaccination Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Pneumococcal Vaccination Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Pneumococcal Vaccination Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Pneumococcal Vaccination Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Pneumococcal Vaccination Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Pneumococcal Vaccination Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Pneumococcal Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Pneumococcal Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Pneumococcal Vaccination Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Pneumococcal Vaccination Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Pneumococcal Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Pneumococcal Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Pneumococcal Vaccination Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Pneumococcal Vaccination Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Pneumococcal Vaccination Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Pneumococcal Vaccination Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Pneumococcal Vaccination Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Value by Country (2024-2029)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Pneumococcal Vaccination Product
Table 112. Pfizer Recent Development
Table 113. GSK Company Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. GSK Pneumococcal Vaccination Product
Table 117. GSK Recent Development
Table 118. MSD Company Information
Table 119. MSD Introduction and Business Overview
Table 120. MSD Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. MSD Pneumococcal Vaccination Product
Table 122. MSD Recent Development
Table 123. CDIBP Company Information
Table 124. CDIBP Introduction and Business Overview
Table 125. CDIBP Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. CDIBP Pneumococcal Vaccination Product
Table 127. CDIBP Recent Development
Table 128. WALVAX Company Information
Table 129. WALVAX Introduction and Business Overview
Table 130. WALVAX Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. WALVAX Pneumococcal Vaccination Product
Table 132. WALVAX Recent Development
Table 133. Sinovac Company Information
Table 134. Sinovac Introduction and Business Overview
Table 135. Sinovac Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Sinovac Pneumococcal Vaccination Product
Table 137. Sinovac Recent Development
Table 138. Bio Kangtai Company Information
Table 139. Bio Kangtai Introduction and Business Overview
Table 140. Bio Kangtai Pneumococcal Vaccination Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Bio Kangtai Pneumococcal Vaccination Product
Table 142. Bio Kangtai Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Pneumococcal Vaccination Market Trends
Table 146. Pneumococcal Vaccination Market Drivers
Table 147. Pneumococcal Vaccination Market Challenges
Table 148. Pneumococcal Vaccination Market Restraints
Table 149. Pneumococcal Vaccination Distributors List
Table 150. Pneumococcal Vaccination Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccination Product Picture
Figure 2. Global Pneumococcal Vaccination Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pneumococcal Vaccination Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Pneumococcal Vaccination Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of PPSV 23
Figure 6. Global PPSV 23 Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of PCV 13
Figure 8. Global PCV 13 Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of PCV 10
Figure 10. Global PCV 10 Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Pneumococcal Vaccination Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Pneumococcal Vaccination Sales Market Share by Type in 2022 & 2029
Figure 13. North America Pneumococcal Vaccination Sales Market Share in Volume by Type in 2022
Figure 14. North America Pneumococcal Vaccination Sales Market Share in Value by Type in 2022
Figure 15. Europe Pneumococcal Vaccination Sales Market Share in Volume by Type in 2022
Figure 16. Europe Pneumococcal Vaccination Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Value by Type in 2022
Figure 19. Latin America Pneumococcal Vaccination Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Pneumococcal Vaccination Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Vaccination Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Vaccination Revenue in 2022
Figure 25. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Child
Figure 27. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Adult
Figure 29. Global Adult Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Pneumococcal Vaccination Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Pneumococcal Vaccination Sales Market Share by Application in 2022 & 2029
Figure 32. North America Pneumococcal Vaccination Sales Market Share in Volume by Application in 2022
Figure 33. North America Pneumococcal Vaccination Sales Market Share in Value by Application in 2022
Figure 34. Europe Pneumococcal Vaccination Sales Market Share in Volume by Application in 2022
Figure 35. Europe Pneumococcal Vaccination Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Pneumococcal Vaccination Sales Market Share in Value by Application in 2022
Figure 38. Latin America Pneumococcal Vaccination Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Pneumococcal Vaccination Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Pneumococcal Vaccination Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Pneumococcal Vaccination Manufacturing Cost Structure
Figure 43. Pneumococcal Vaccination Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed